SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-20-001710
Filing Date
2020-03-13
Accepted
2020-03-13 15:36:11
Documents
75
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_031320p.htm 10-K 1094264
2 EXHIBIT 4.1 exh_41.htm EX-4.1 12277
3 EXHIBIT 10.18 exh_1018.htm EX-10.18 45264
4 EXHIBIT 10.83 exh_1083.htm EX-10.83 747348
5 EXHIBIT 21 exh_21.htm EX-21 2106
6 EXHIBIT 23 exh_23.htm EX-23 5762
7 EXHIBIT 31.1 exh_311.htm EX-31.1 7919
8 EXHIBIT 32.1 exh_321.htm EX-32.1 4277
15 GRAPHIC graph1.jpg GRAPHIC 16113
  Complete submission text file 0001171843-20-001710.txt   7121596

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE bcrx-20191231.xml EX-101.INS 1190023
10 XBRL SCHEMA FILE bcrx-20191231.xsd EX-101.SCH 72519
11 XBRL CALCULATION FILE bcrx-20191231_cal.xml EX-101.CAL 55080
12 XBRL DEFINITION FILE bcrx-20191231_def.xml EX-101.DEF 498026
13 XBRL LABEL FILE bcrx-20191231_lab.xml EX-101.LAB 468090
14 XBRL PRESENTATION FILE bcrx-20191231_pre.xml EX-101.PRE 526711
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 20712407
SIC: 2836 Biological Products, (No Diagnostic Substances)